Felipe de Arriba
- Hematology top 0.5%
- Molecular Biology top 10%
- Oncology top 5%
- Genetics top 5%
- Immunology
- Co-authors
- Jesús F. San MiguelJuan José LahuertaJavier de la RubiaMaría‐Victoria MateosLaura RosiñolJoan BladéAlbert OriolMiguel‐Teodoro Hernández
- Topics
- Multiple Myeloma Research and Treatments (47 papers)Protein Degradation and Inhibitors (21 papers)Peptidase Inhibition and Analysis (16 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Felipe de Arriba
67 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 75
- Hematology 1.6k
- Molecular Biology 1.1k
- Oncology 783
- Genetics 249
- Immunology 165
Countries citing papers authored by Felipe de Arriba
This map shows the geographic impact of Felipe de Arriba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felipe de Arriba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felipe de Arriba more than expected).
Fields of papers citing papers by Felipe de Arriba
This network shows the impact of papers produced by Felipe de Arriba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felipe de Arriba. The network helps show where Felipe de Arriba may publish in the future.
Co-authorship network of co-authors of Felipe de Arriba
This figure shows the co-authorship network connecting the top 25 collaborators of Felipe de Arriba. A scholar is included among the top collaborators of Felipe de Arriba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felipe de Arriba. Felipe de Arriba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 19 | |
| 5 | 7 | |
| 6 | 14 | |
| 7 | 6 | |
| 8 | 7 | |
| 9 | 13 | |
| 10 | 107 | |
| 11 | 12 | |
| 12 | 348 | |
| 13 | 157 | |
| 14 | 0 | |
| 15 | 70 | |
| 16 | 193 | |
| 17 | 60 | |
| 18 | 19 | |
| 19 | 1 | |
| 20 | 6 |
About Felipe de Arriba
Felipe de Arriba is a scholar working on Hematology, Oncology and Genetics, having authored 71 papers that have together received 1.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (47 papers), Protein Degradation and Inhibitors (21 papers) and Peptidase Inhibition and Analysis (16 papers). The work is most often cited by research in Hematology (1.6k citations), Oncology (783 citations) and Genetics (249 citations). Felipe de Arriba has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Jesús F. San Miguel, Juan José Lahuerta, Javier de la Rubia, María‐Victoria Mateos, Laura Rosiñol, Joan Bladé, Albert Oriol, Miguel‐Teodoro Hernández, Anna Sureda and Bruno Paiva. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.